Markets Edge — Capital flows, CMO moves, M&A

ISABELLA'S ISLAY M&A Intelligence May 7, 11:01 AM EDT

American Express Global Business Travel

WSJ ↗

Amex GBT enters take-private deal valued at $6.3B

American Express Global Business Travel agreed to be acquired in a take-private transaction valuing the company at $6.3 billion, marking a significant consolidation in the corporate travel management sector.

ReadingCorporate travel is now a consolidation play, not a growth story. The multiple paid here sets the floor for comparable assets.

WatchThe next two take-privates in travel tech will price within 90 days. The market is signaling appetite.

Read full analysis → Original ↗

m&aprivate equitytravel techtake-private

HENRI IV M&A Intelligence May 7, 11:01 AM EDT

Bullish / Equiniti

The Block ↗

Bullish acquires Equiniti in $4.2B deal merging tokenization with transfer agent

Bullish, the crypto exchange platform, agreed to acquire Equiniti, a global transfer agent and financial services provider, in a $4.2 billion deal combining blockchain tokenization infrastructure with traditional institutional settlement services.

ReadingThe merger of Bullish and Equiniti signals that tokenization infrastructure requires institutional-grade back-office. DIY settlement is over.

WatchExpect two more infrastructure acquisitions in crypto within 120 days. The category is consolidating around licensed operators.

Read full analysis → Original ↗

m&acryptoequinititokenization

MACALLAN 1926 Venture Intelligence May 7, 11:01 AM EDT

Odyssey Therapeutics

Renaissance Capital ↗

Odyssey Therapeutics prices $225M IPO, autoimmune focus intact

Odyssey Therapeutics, a biotech company focused on autoimmune and inflammatory diseases, set terms for a $225 million IPO, pricing this week to fund its clinical pipeline.

ReadingBiotech IPO appetite is returning, but only for single-indication or highly-focused franchises. Broad platforms stay private.

WatchTwo more biotech IPOs will price in the next 45 days, both in narrow therapeutic areas.

Read full analysis → Original ↗

ipobiotechfundraisingautoimmune

LOUIS XIII Healthcare Intelligence May 7, 11:01 AM EDT

Mobia Medical

Renaissance Capital ↗

Mobia Medical prices $150M IPO for nerve stimulation devices

Mobia Medical, a medical device company focused on nerve stimulation technology, set terms for a $150 million IPO, pricing this week to expand its product development and commercialization efforts.

ReadingMedical device IPOs return to single-system companies with FDA-cleared products and clear margin trajectories.

WatchOne more medical device IPO prices within 60 days. If it clears $100M in valuation, device capital is fully reopened.

Read full analysis → Original ↗

ipomedical deviceshealthcarefundraising

PAPPY 23 Capital Markets May 7, 11:01 AM EDT

Suja Life

Stock Titan ↗

Suja Life debuts on Nasdaq after pricing 8.9M shares at $21

Suja Life, a cold-pressed juice and functional beverage company, debuted on Nasdaq following its pricing at $21 per share, raising capital to fund expansion and product development.

ReadingCPG IPOs are back but only for brands with documented unit economics and retail distribution at scale. Concept plays stay private.

WatchThe next CPG IPO will price within 30 days. If it clears $25 per share, consumer-facing capital is fully reopened.

Read full analysis → Original ↗

ipocpgbeveragenasdaq

JOHNNIE BLUE Capital Markets May 7, 11:01 AM EDT

Crypto Asset Class (Multi-issuer)

TradingView / CoinDesk ↗

Crypto fund inflows hit $224M as institutional sentiment reverses

Cryptocurrency investment products recorded $224 million in inflows this week, with Bitcoin ETFs hitting their highest assets under management since February and XRP emerging as the institutional favorite.

ReadingInstitutional crypto reallocation is underway. XRP's institutional preference signals a rotation toward settlement-layer assets, not application-layer tokens.

WatchIf inflows sustain above $200M per week for four consecutive weeks, long-term capital has returned. Expect derivative launches within 60 days.

Read full analysis → Original ↗

cryptofund flowsxrpinstitutional

WELL POUR Capital Markets May 7, 11:01 AM EDT

SPAC (Undisclosed)

Stock Titan ↗

New SPAC prices $100M IPO, NYSE debut scheduled May 7

A new special purpose acquisition company priced a $100 million IPO and is set to debut on the New York Stock Exchange on May 7, continuing the slow reemergence of SPAC capital.

ReadingSPACs have returned to fundamentals: proven sponsors, $100M+ checks, and clear sector theses. The blank-check era is over.

WatchIf the SPAC closes above IPO price on day one, SPAC demand has stabilized. Expect two more in the next 45 days.

Read full analysis → Original ↗

spacipocapital marketsnyse